Nanomaterial labels in electrochemical immunosensors and immunoassays
نویسندگان
چکیده
منابع مشابه
Nanomaterial-Based Electrochemical Immunosensors for Clinically Significant Biomarkers
Nanotechnology has played a crucial role in the development of biosensors over the past decade. The development, testing, optimization, and validation of new biosensors has become a highly interdisciplinary effort involving experts in chemistry, biology, physics, engineering, and medicine. The sensitivity, the specificity and the reproducibility of biosensors have improved tremendously as a res...
متن کاملElectrochemical Immunosensors and Aptasensors
Since the first electrochemical biosensor for glucose detection, pioneered in 1962 by Clark and Lyons [1], research and application in the field has grown at an impressive rate and we are still witnessing a continuing evolution of research on this topic [2]. According to the definition recommended by IUPAC some years later [3], a biosensor is a self-contained device that is capable of providing...
متن کاملRecent Advances in Electrochemical Immunosensors
Immunosensors have experienced a very significant growth in recent years, driven by the need for fast, sensitive, portable and easy-to-use devices to detect biomarkers for clinical diagnosis or to monitor organic pollutants in natural or industrial environments. Advances in the field of signal amplification using enzymatic reactions, nanomaterials such as carbon nanotubes, graphene and graphene...
متن کاملElectrochemical and chemiluminescent immunosensors for tumor markers.
The determination of serum tumor markers plays an important role in clinical diagnoses for the patients with certain tumor-associated disease. Although many commercial kits have been applied in clinical immunoassays, conventional methods always have some disadvantages, resulting in the need of other new, efficient, and easily automated methods. Immunosensors, considered as a major development i...
متن کاملMultiplexed Electrochemical Immunosensors for Clinical Biomarkers
Management and prognosis of disease requires the accurate determination of specific biomarkers indicative of normal or disease-related biological processes or responses to therapy. Moreover since multiple determinations of biomarkers have demonstrated to provide more accurate information than individual determinations to assist the clinician in prognosis and diagnosis, the detection of several ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Talanta
سال: 2007
ISSN: 0039-9140
DOI: 10.1016/j.talanta.2007.10.014